Will American Reality Capital Healthcare Trust (HCT) Stock Be Affected By Investigation Of Board?

NEW YORK (TheStreet) -- Faruqi and Faruqi, a New York-based national securities firm, announced today that it's investigating the board of directors of American Reality Capital Healthcare Trust Inc. (HCT) regarding the sale of the company to Ventas Inc. (VTR).

Shares of American Reality Capital Healthcare Trust are up 8.34% to $10.78 on news of the $2.6 billion sale.

The securities firm said they are investigating the board to determine if it breached its fiduciary duties to the company's shareholders by not conducting a fair sales process "and whether and by how much this proposed transaction undervalues the company to the detriment of ARC Healthcare's shareholders."

Must ReadWarren Buffett's 25 Favorite Stocks 

HCT Chart HCT data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: UAN, OLN, HCT

Healthcare REITs Combine in $3 Billion Stock-for-stock Deal

American Realty Capital Healthcare Trust (HCT) Stock Sinks With American Realty Capital Properties

Monday's Ex-Dividends To Watch: IDCC, FEIC, HCT

Dividend Watch: 3 Stocks Going Ex-Dividend Tomorrow: BBEP, BOBE, HCT